Two studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate, but ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with ...

A range of things can cause a psoriasis flare-up, including stress, cold weather (hello winter!), skin injuries, certain ...

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) ...

EULAR - The European Alliance of Associations for Rheumatology - recommends a treat-to-target approach, and suggests more ...

Two recent studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate2,3, but these did not ...

Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.